SCHEMBL14013334

SCHEMBL14013334

CCOC(=O)CCCN(CC)c1cc(OC)c(-c2c3ccc(=[N+](C)C)cc-3oc3cc(N(C)C)ccc23)cc1N(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.45
▸ BLM P54132 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ THRB P10828 2/20 0.45
▸ RECQL P46063 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ P2RY6 Q15077 1/20 0.43
▸ ITPR1 Q14643 1/20 0.39
▸ CA12 O43570 3/20 0.38
▸ CA1 P00915 3/20 0.38
▸ CA2 P00918 3/20 0.38
▸ CA9 Q16790 3/20 0.38
▸ USP2 O75604 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38
▸ HTR3A P46098 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14013314 0.95 MEN1 (0.45) MEN1BLMKMT2ATHRBRECQL
SCHEMBL14163350 0.94 MEN1 (0.46) MEN1BLMKMT2ATHRBRECQL
SCHEMBL14013423 0.94 MEN1 (0.43) MEN1BLMKMT2ATHRBRECQL
Hydrochloric Acid SCHEMBL3997760 0.93 MEN1 (0.42) MEN1BLMKMT2ATHRBRECQL
SCHEMBL14013337 0.92 MEN1 (0.49) MEN1BLMKMT2ATHRBRECQL
SCHEMBL19927823 0.91 P2RY6 (0.47) MEN1BLMKMT2ATHRBRECQL
SCHEMBL14884221 0.89 MEN1 (0.39) MEN1BLMKMT2ATHRBRECQL
SCHEMBL14013338 0.88 MEN1 (0.41) MEN1BLMKMT2ATHRBRECQL
SCHEMBL14013318 0.87 MEN1 (0.47) MEN1BLMKMT2ATHRBRECQL
SCHEMBL16986027 0.87 MEN1 (0.39) MEN1BLMKMT2ATHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9939454-B2 Fluorogenic pH sensitive dyes and their method of use Life Technologies Corporation (US) 2018-04-10 — — US disclosed
US-9910051-B2 Fluorogenic pH sensitive dyes and their method of use Life Technologies Corporation (US) 2018-03-06 — — US disclosed
US-20160139158-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE Life Technologies Corporation 2016-05-19 — — US disclosed
US-20160139158-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE Life Technologies Corporation 2016-05-19 — — US disclosed
US-20150037834-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE Life Technologies Corporation 2015-02-05 — — US disclosed
US-20150037834-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE Life Technologies Corporation 2015-02-05 — — US disclosed
EP-2727965-A1 Fluorogenic pH sensitive dyes and their method of use Life Technologies Corporation (US) 2014-05-07 — — EP disclosed
US-20130102021-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE Life Technologies Corporation (US) 2013-04-25 — — US disclosed
US-20080274907-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE INVITROGEN CORPORATION (US) 2008-11-06 — — US disclosed
US-20080274907-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE INVITROGEN CORPORATION (US) 2008-11-06 — — US disclosed
WO-2008076524-A2 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE Life Technologies Corporation (US) 2008-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274907-A1 FLUOROGENIC PH SENSITIVE DYES AND THEIR METHOD OF USE SLC11A2, MAN2B1, CD47 MEN1 1603/4885BLM 3585/4885KMT2A 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback